{"extraction_ratio": 0.96, "to_compare": [{"generated": ["progressive mobilization", "complete normalization of the laboratory findings"], "gold": []}, {"generated": ["trabectedin", "heavy toxicity", "alternative herbal medicine", "rhabdomyolysis"], "gold": []}, {"generated": ["abdominal mass", "complete margin negative (R0) resection"], "gold": []}, {"generated": ["lesion size", "location"], "gold": []}, {"generated": ["co-morbidity", "other drugs"], "gold": []}, {"generated": ["ancillary medications", "chemotherapeutic drugs", "narrow therapeutic index", "combinations in oncology practice", "prolonged life expectancy"], "gold": []}, {"generated": ["death receptor", "transport mechanisms", "unknown mechanisms"], "gold": []}, {"generated": ["health risks", "medicinal cannabis"], "gold": []}, {"generated": ["COMT", "HTR2A"], "gold": []}, {"generated": ["dopamine concentrations"], "gold": []}, {"generated": ["pharmacogenomic data", "pharmacodynamic", "pharmacokinetic"], "gold": []}, {"generated": ["chronic back pain", "chronic neck pain", "alcohol dependence", "nicotine dependence", "chronic shoulder pain", "spinal stenosis", "frequent falls", "vitamin D deficiency", "mild kidney disease"], "gold": []}, {"generated": ["tremors"], "gold": []}, {"generated": ["additional medication for pain control"], "gold": []}, {"generated": ["sources of the product", "healthy subjects vs. patients", "routes of administration", "pain models"], "gold": []}, {"generated": ["dopamine levels", "inhibitory neurotransmitter levels"], "gold": ["dopamine levels"]}, {"generated": ["COMT Met/Met"], "gold": []}, {"generated": ["hallucinations"], "gold": []}, {"generated": ["morphine"], "gold": []}, {"generated": ["Katie Meyer"], "gold": []}, {"generated": ["CAM", "conventional medicines"], "gold": []}, {"generated": ["CAM"], "gold": []}, {"generated": ["range"], "gold": []}, {"generated": ["therapeutic indices"], "gold": []}, {"generated": ["HDIs"], "gold": []}, {"generated": ["pharmacogenomics studies", "clinic study", "HDIs", "important herb products"], "gold": []}, {"generated": ["TPMT gene", "hypoglycemic effect"], "gold": ["The rs1142345 (A>G) SNP in the thiopurine S-methyltransferase (TPMT) gene"]}, {"generated": ["clinical effect of traditional hypoglycemic herbs"], "gold": ["rs1142345"]}, {"generated": ["AUC: concentration-time curve", "PM", "EMs"], "gold": ["AUC: concentration-time curve"]}, {"generated": ["conventional therapeutic drugs", "herbal remedies"], "gold": []}, {"generated": ["Akoko", "Lifui", "Faangum", "Sasanemasa/Sesemasa"], "gold": []}, {"generated": ["cytochrome P450"], "gold": []}, {"generated": ["CYP2C9", "CYP2C19", "CYP1A2"], "gold": []}, {"generated": ["K A", "metabolites"], "gold": []}, {"generated": ["% yield", "bioavailable concentration"], "gold": ["bioavailability", "bioavailable concentration"]}, {"generated": ["DDI studies", "HDI"], "gold": []}, {"generated": ["TDI effects", "intermediary metabolites"], "gold": []}, {"generated": ["water"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["regeneration system", "binary pump", "Micromass Xevo tandem quadrupole mass spectrometric detector", "column oven", "ESI probe", "vacuum degasser", "autosampler", "UPLC system", "NADP Phytofingerprinting", "serial dilutions", "Acquity BEH C18 column"], "gold": []}, {"generated": ["DDI models", "IVIVE", "HDI"], "gold": []}, {"generated": ["OATs", "SLC22 family members"], "gold": ["SLC22", "OATs"]}, {"generated": ["unique substrates"], "gold": ["Oat1", "Oat3"]}, {"generated": ["Danshen components", "clinical pharmacokinetic profile"], "gold": ["transporter families", "the OATs"]}, {"generated": ["genotype", "pharmacodynamics", "St John's wort", "gliclazide", "pharmacokinetics", "CYP2C9"], "gold": []}, {"generated": ["alternative medicines"], "gold": []}, {"generated": ["6\u03b2", "7\u03b2", "6\u03b1", "7\u03b1"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["CYP2C9*3", "CYP2C9*2"], "gold": []}, {"generated": ["PCR", "human genomic DNA"], "gold": []}, {"generated": ["grapefruit", "caffeine-containing beverages"], "gold": []}, {"generated": ["(2003)"], "gold": []}, {"generated": ["CYP2C9*3 allele", "tolbutamide", "glipizide", "CL/Fs"], "gold": ["CL/Fs"]}, {"generated": [], "gold": []}, {"generated": ["serological titers for acute CMV", "serological titers for Epstein Barr virus"], "gold": []}, {"generated": ["Antinuclear antibody (ANA)", "smooth muscle antibody"], "gold": ["Antinuclear antibody (ANA", "smooth muscle antibody"]}, {"generated": ["plasma cell rich interface hepatitis", "periportal hepatocyte apoptosis", "cholangiolar proliferation", "chronic hepatitis", "portal tracts"], "gold": ["periportal hepatocyte"]}, {"generated": ["clinicopathological features"], "gold": []}, {"generated": ["right upper quadrant abdominal pain", "fatigue", "lower extremity edema"], "gold": []}, {"generated": ["vasomotor symptoms of menopause"], "gold": []}, {"generated": ["liver failure"], "gold": []}, {"generated": ["immunogen", "autoimmune response", "hapten"], "gold": []}, {"generated": ["Naranjo Causality Scale"], "gold": []}, {"generated": ["black cohosh hepatotoxicity"], "gold": []}, {"generated": ["third-generation fluoroquinolone antibiotic family"], "gold": []}, {"generated": ["Polygonum capitatum", "Relinqing\u00ae granule", "LVFX"], "gold": []}, {"generated": ["pharmacokinetic features"], "gold": []}, {"generated": ["puerarin", "rat tissue homogenate"], "gold": []}, {"generated": ["42 mg\u00b7kg"], "gold": []}, {"generated": ["complex matrices", "LVFX"], "gold": []}, {"generated": ["integrities"], "gold": []}, {"generated": ["LVFX", "distribution rate"], "gold": []}, {"generated": ["pharmacokinetic level"], "gold": []}, {"generated": ["pharmacodynamic interactions", "pharmacokinetic interactions"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["efficacy"], "gold": []}, {"generated": ["anti-inflammatory", "anti-osteoporosis", "antioxidant", "anticancer"], "gold": []}, {"generated": ["Dulbecco\u2019s Modified Eagle Medium (DMEM)", "Penicillin-streptomycin", "HEPES", "Sodium Pyruvate", "Minimal Essential Medium (MEM)", "Trypsin EDTA", "Hanks balanced salt solution (HBSS)"], "gold": []}, {"generated": ["non-essential amino acids", "MDCK-II cells", "DMEM", "reversible inhibition", "FBS"], "gold": []}, {"generated": ["alkyl phenols", "triterpene glycosides"], "gold": []}, {"generated": ["P-gp"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["CYP2C8", "CYP3A4", "CYP2C9", "Cytochrome P450 enzymes"], "gold": []}, {"generated": ["anti-diabetic", "cardio-protective effects", "anti-obesity"], "gold": []}, {"generated": ["CYP2C8", "CYP3A4", "CYP2C9"], "gold": []}, {"generated": ["CYP2C8", "CYP3A4", "CYP2C9"], "gold": []}, {"generated": ["methanol", "acetonitrile", "DMSO"], "gold": []}, {"generated": ["CYP2C8", "CYP3A4", "CYP2C9"], "gold": []}, {"generated": ["CYP2C9", "CYP3A4 activity", "FRE"], "gold": []}, {"generated": ["Stock solutions", "10 mg/mL"], "gold": []}, {"generated": ["sulfaphenazole", "quercetin", "ketoconazole"], "gold": []}, {"generated": ["safety", "pharmacodynamics"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Echinacea", "participants"], "gold": []}, {"generated": ["traditional hypoglycemic herbs"], "gold": []}, {"generated": ["statistically significant"], "gold": []}, {"generated": ["pharmacokinetics of docetaxel"], "gold": []}, {"generated": ["caffeic acid derivatives", "alkylamides"], "gold": []}, {"generated": ["docetaxel", "NCI CTCAE, version 3.0", "grade 3 and 4 toxicities"], "gold": []}, {"generated": ["plasma"], "gold": []}, {"generated": ["elimination half-life (t1/2)", "AUC0\u2013\u221e", "maximum plasma concentration (Cmax)"], "gold": ["area under the plasma concentration\u2013time curve from time zero to infinity (AUC0\u2013\u221e)", "elimination half-life (t1/2)", "maximum plasma concentration (Cmax)"]}, {"generated": ["t1/2", "Cmax", "AUC0\u2013\u221e"], "gold": ["AUC0\u2013\u221e", "t1/2", "Cmax"]}, {"generated": ["docetaxel AUC0\u2013\u221e"], "gold": ["AUC0\u2013\u221e"]}, {"generated": ["dose", "dosing regimen", "midazolam", "CYP3A4 induction"], "gold": []}, {"generated": ["total amount of extract"], "gold": []}, {"generated": ["DTAI", "alkylamides"], "gold": []}, {"generated": ["DTAI", "alkylamide content"], "gold": []}, {"generated": ["CYP3A4 induction"], "gold": []}, {"generated": ["dexamethasone", "docetaxel pretreatment"], "gold": []}, {"generated": ["plasma levels of docetaxel"], "gold": []}, {"generated": ["tumour progression"], "gold": []}, {"generated": ["CYP3A4-mediated interactions"], "gold": []}, {"generated": ["p-glycoprotein (p-gp)"], "gold": []}, {"generated": ["ascorbic acid-EDTA solution", "ethyl gallate", "plasma", "ethyl acetate"], "gold": []}, {"generated": ["M/Z values"], "gold": []}, {"generated": ["EC", "EGC", "calibration curve range", "EGCG", "ECG"], "gold": []}, {"generated": ["DNA"], "gold": []}, {"generated": ["G2677T", "C3435T", "rs1128503", "G2677A", "C1236T", "ABCB1", "rs2032582", "rs1045642"], "gold": []}, {"generated": ["adverse events"], "gold": []}, {"generated": ["adverse events"], "gold": []}, {"generated": ["EC", "EGC", "EGCG", "pharmacokinetics parameters", "ECG", "AUC", "concentration\u2013time profiles"], "gold": ["AUC"]}, {"generated": ["AUC"], "gold": ["AUC"]}, {"generated": ["systemic exposure"], "gold": []}, {"generated": ["AUC", "Subject baseline characteristics"], "gold": ["AUC", "AUC"]}, {"generated": ["biliary excretion"], "gold": ["Biliary excretion", "urinary excretion"]}, {"generated": ["plasma concentrations of ginsenosides"], "gold": []}, {"generated": ["Mrp2 substrate drug", "biliary excretion"], "gold": []}, {"generated": ["Rg3", "Rh1", "Re"], "gold": []}, {"generated": ["P-gp", "bile acid receptor"], "gold": []}, {"generated": ["rheumatoid arthritis symptoms"], "gold": []}, {"generated": ["MTX", "red ginseng"], "gold": []}, {"generated": ["Mrp2 regulation changes"], "gold": []}, {"generated": ["total RNA"], "gold": []}, {"generated": ["total protein"], "gold": []}, {"generated": ["pharmacokinetic studies"], "gold": []}, {"generated": ["red ginseng extract"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["ginsenosides"], "gold": []}, {"generated": ["Bautista et al."], "gold": []}, {"generated": ["Dybro et al."], "gold": []}, {"generated": ["DST", "AC"], "gold": []}, {"generated": ["3.5 \u03bcm"], "gold": []}, {"generated": ["supernatant"], "gold": []}, {"generated": ["liver microsomes", "metabolic rate", "maximum plasma concentration"], "gold": []}, {"generated": ["half-life"], "gold": []}, {"generated": ["acetonitrile"], "gold": []}, {"generated": ["selectivity", "plasma samples"], "gold": []}, {"generated": ["concentration range"], "gold": []}, {"generated": ["accuracy", "precision"], "gold": []}, {"generated": ["effective plasma drug concentration"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Western drugs"], "gold": []}, {"generated": ["digoxin plasma concentration"], "gold": []}, {"generated": ["digoxin"], "gold": []}, {"generated": ["Chuanxiong", "Tapinanthus sessilifolius", "Ginkgo biloba L.", "Biantaobanjiuju", "Carica papaya", "P-gP"], "gold": []}, {"generated": ["AUC"], "gold": ["AUC"]}, {"generated": ["Li Xin"], "gold": []}, {"generated": ["flavane polymers", "vascular dilation", "blood pressure", "cardiovascular system", "ventricular tachycardia", "flavonoid glycoside", "ventricular fibrillation", "heart rhythm", "digoxin-induced arrhythmias", "QRS interval prolongation", "ventricular precontraction"], "gold": ["blood pressure", "heart rhythm"]}, {"generated": ["yang", "blood", "yin", "qi"], "gold": []}, {"generated": ["TCM formulations"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["TCM formulations", "digoxin"], "gold": []}, {"generated": ["herb-drug interactions"], "gold": []}, {"generated": ["cytochrome P450"], "gold": ["cytochrome P450 (P450)", "monooxygenase forms"]}, {"generated": ["systemic levels of the victim drug"], "gold": []}, {"generated": ["type of extract (CAW)", "drug-metabolizing enzymes"], "gold": []}, {"generated": ["nuclear receptor agonists", "drug disposition", "transporter function"], "gold": ["nuclear receptor"]}, {"generated": ["Plant Material", "C. asiatica", "CAW-R61J"], "gold": []}, {"generated": ["CAW-R61H", "CAW-R61F", "dried CA"], "gold": []}, {"generated": ["DMSO"], "gold": ["DMSO", "DMSO"]}, {"generated": ["ambient temperature"], "gold": []}, {"generated": ["NADPH", "P450 enzyme activity", "IC50 values"], "gold": ["Potential TDI of P450 enzyme activity", "IC50", "NADPH"]}, {"generated": [], "gold": []}, {"generated": ["four-parameter sigmoid (Hill) model", "percentage control value", "concentration-response", "IC50 values"], "gold": ["the IC50 values", "the concentration-response (percentage control value)"]}, {"generated": ["logEC50"], "gold": ["logEC50", "logIC50"]}, {"generated": ["curve fitting"], "gold": []}, {"generated": ["dmd.120.090860f1"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": [""], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["CYP2C9", "CYP2B6", "CYP1A2"], "gold": ["IC50", "IC50"]}, {"generated": [""], "gold": []}, {"generated": ["dmd.120.090860f3"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["triplicate determinations"], "gold": []}, {"generated": ["human P450 forms", "centelloids", "human liver microsomes", "CYP2C19", "CYP2D6", "CYP2C9", "CYP3A4"], "gold": ["P450", "CYP2C19, CYP3A4, CYP2D6, and CYP2C9"]}, {"generated": ["plasma concentrations"], "gold": ["plasma concentrations for these compounds"]}, {"generated": ["CAW-R61J compounds", "IC50 values"], "gold": ["IC50", "in vivo concentration"]}, {"generated": ["phase II drug-metabolizing enzymes"], "gold": ["phase II drug-metabolizing enzymes"]}, {"generated": ["tolerability", "safety", "DDI potential"], "gold": []}, {"generated": ["chronic kidney disease", "hypertension"], "gold": []}, {"generated": ["fimasartan-amide", "hydrochlorothiazide", "fimasartan", "amlodipine"], "gold": []}, {"generated": ["standard calibration curves", "concentrations"], "gold": []}, {"generated": ["berberine (IS)", "1 ng/mL"], "gold": []}, {"generated": ["post-preparative stability", "QC samples", "autosampler", "6 \u00b0C"], "gold": []}, {"generated": ["hydrochlorothiazide", "fimasartan", "amlodipine"], "gold": []}, {"generated": ["jejunal segments", "pre-warmed saline"], "gold": []}, {"generated": ["berberine", "acetonitrile", "amlodipine"], "gold": []}, {"generated": ["ionization mode", "mass transition from Q1 to Q3"], "gold": []}, {"generated": ["hydrochlorothiazide", "chromatograms", "fimasartan", "amlodipine"], "gold": []}, {"generated": ["Guideline of Bioanalytical method validation", "intra-day accuracy", "standard curve sample", "QC sample", "inter-day accuracy"], "gold": []}, {"generated": ["fimasartan monotherapy", "hypertension", "fimasartan combination therapy"], "gold": []}, {"generated": ["mass fragmentation patterns"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["CV", "mean"], "gold": []}, {"generated": ["HAART administration"], "gold": []}, {"generated": ["quality of life"], "gold": []}, {"generated": ["nausea", "vomiting", "fever", "liver damage", "dyslipidemia", "headache", "diarrhoea"], "gold": []}, {"generated": ["medicinal plants"], "gold": []}, {"generated": ["mechanisms of action"], "gold": []}, {"generated": ["CYP2B6"], "gold": []}, {"generated": ["bioavailable concentration", "soluble extract", "GI tract"], "gold": ["bioavailability", "bioavailable concentration"]}, {"generated": ["Chlorogenic acid", "Caffeic acid", "Epicatechin", "p-Coumaric acid", "Catechin"], "gold": []}, {"generated": ["mechanistic studies", "phytochemical profiling", "drug interacting constituents"], "gold": []}, {"generated": ["CYP2B6"], "gold": []}, {"generated": ["University of Cape Town Human Research Ethics committee", "Ethical approval", "HREC REF: 826/2014"], "gold": []}, {"generated": ["supernatant", "purified water", "solid residue"], "gold": []}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["drug interactions"], "gold": []}, {"generated": ["7 \u00b1 1-day washout period"], "gold": []}, {"generated": ["GGT"], "gold": []}, {"generated": ["1000 mg", "8 tablets", "maximum dose", "AAP dose"], "gold": []}, {"generated": ["GGT 7680 mg once daily", "AAP 1000 mg once daily", "AAP 1000 mg \u00d7 4 times daily"], "gold": []}, {"generated": ["AAP dosage", "GGT"], "gold": []}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pharmacokinetic (PK) parameters"], "gold": []}, {"generated": ["CYP3A4", "CYP2D6", "CYP1A2", "CYP2E1"], "gold": []}, {"generated": ["patients taking prescription medications", "individuals greater than 65 years of age", "herbal supplement usage"], "gold": []}, {"generated": ["CYP substrates", "CYP enzymes", "pharmacokinetics"], "gold": []}, {"generated": ["probe drug administration"], "gold": []}, {"generated": ["ultraviolet absorption spectra", "retention times"], "gold": []}, {"generated": ["serious adverse events"], "gold": []}, {"generated": ["Phenotypic Ratio (CYP)"], "gold": []}, {"generated": ["midazolam clearance", "phenotypic ratio"], "gold": ["area-under-the-curve", "clearance"]}, {"generated": [""], "gold": []}, {"generated": ["St. John\u2019s wort"], "gold": []}, {"generated": ["CYP2E1 responsivity", "allyl sulfide content"], "gold": []}, {"generated": ["anticoagulant therapy"], "gold": []}, {"generated": ["platelet activating factor"], "gold": []}, {"generated": ["G. biloba", "CYP isoforms", "herb-drug interactions"], "gold": []}, {"generated": ["CYP isoforms", "Panax ginseng"], "gold": []}, {"generated": ["CYP2C9", "ginseng-mediated induction"], "gold": []}, {"generated": ["herb-drug interactions"], "gold": []}, {"generated": ["plasma quinine", "3-hydroxyquinine"], "gold": []}, {"generated": ["kolaviron", "biflavonoid complex", "saponins", "alkaloids", "aluminum", "calcium", "benxophenones", "magnesium", "copper", "phenols", "tannins", "xanthones", "metallic ions"], "gold": []}, {"generated": ["adverse side effects from taking G. kola seeds", "breastfeeding", "pregnancy", "histories of hypersensitivity to quinine or similar agents"], "gold": []}, {"generated": ["certified healthy", "written informed consent"], "gold": []}, {"generated": ["quinine sulphate tablets", "600 mg"], "gold": []}, {"generated": ["quinine sulphate tablets", "concurrently with the scheduled dose of G. kola", "time zero", "1, 2, 3,4, 6, 8, 12, 24, 36 and 48 h", "quinine alone"], "gold": []}, {"generated": ["quinine", "3-hydroxyquinine"], "gold": []}, {"generated": ["AUC0\u2013\u221e"], "gold": ["AUC0\u2013\u221e"]}, {"generated": ["dizziness"], "gold": []}, {"generated": ["trace metals", "quinine", "flavonoids"], "gold": ["Cmax", "tmax"]}, {"generated": ["T1/2", "CL/F"], "gold": ["T1/2", "CL/F"]}, {"generated": [""], "gold": []}, {"generated": ["77 additional participants"], "gold": []}, {"generated": ["TCAM"], "gold": []}, {"generated": ["failure differences"], "gold": []}, {"generated": ["QRS duration", "PR interval", "corrected QT interval (QTc)"], "gold": ["the PR interval", "QRS duration", "corrected QT interval (QTc)"]}, {"generated": ["HDL", "LDL", "P-value for interaction effect of groups over time"], "gold": ["HDL (high density lipoprotein)", "LDL (low density lipoprotein)"]}, {"generated": [], "gold": []}, {"generated": [], "gold": []}, {"generated": ["prevalence"], "gold": []}, {"generated": ["Chronic kidney disease (CKD)"], "gold": []}, {"generated": ["drug interactions"], "gold": []}, {"generated": ["marital status", "educational status", "age", "occupational status", "sex"], "gold": []}, {"generated": ["male/female ratio", "age group"], "gold": []}, {"generated": ["congenital kidney disease", "acute kidney injury", "polycystic kidney disease", "drug-induced renal failure"], "gold": []}, {"generated": ["age range of 50\u201370 years", "herbal usage prevalence"], "gold": []}, {"generated": ["age groups"], "gold": []}, {"generated": ["respiratory problems", "common cold"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["TEM", "Karnofsky performance status scale"], "gold": []}, {"generated": ["residual tumor", "positron emission tomography"], "gold": []}, {"generated": ["education about the risk of interactions with herbal formulas"], "gold": []}, {"generated": ["incubation", "normal saline", "whole blood"], "gold": []}, {"generated": ["International normalized ratio"], "gold": ["International normalized ratio", "International normalized ratio"]}, {"generated": ["clotting time", "factor activity"], "gold": ["clotting time"]}, {"generated": ["apparent volume of distribution (V/F)", "half-life", "apparent clearance (CL/F)"], "gold": ["half-life", "CL/F", "AUC0\u2212\u221e", "CL/kel"]}, {"generated": ["S-warfarin concentration", "prothrombin complex activity", "INR data"], "gold": ["prothrombin complex activity (PCA", "INR"]}, {"generated": [], "gold": []}, {"generated": ["fu", "CL/F", "AUC", "CL/Fs"], "gold": ["tmax", "Cmax", "AUC", "CL/F", "tmax", "Cmax", "t1/2", "AUC", "CL/F", "AUC, area under the plasma concentration\u2013time curve", "CL, clearance", "CL/F, apparent clearance", "Cmax, maximum concentration", "F, bioavailability", "tmax, time to Cmax"]}, {"generated": ["population PKPD parameter estimates"], "gold": []}, {"generated": ["AUC of S-warfarin"], "gold": ["AUC"]}, {"generated": ["atrial fibrillation"], "gold": []}, {"generated": ["cranberry juice", "pharmacodynamic interactions", "warfarin"], "gold": []}, {"generated": ["herb\u2013drug interaction", "complementary medicines"], "gold": []}, {"generated": ["anticancer drugs"], "gold": []}, {"generated": ["CYP 3A4"], "gold": []}, {"generated": ["the elderly"], "gold": []}, {"generated": ["tablets", "capsules", "daily doses", "valerian root extracts"], "gold": []}, {"generated": ["valeriana", "valerian"], "gold": []}, {"generated": ["potential bias in the presentation of results and conclusions", "completeness and validity of data", "clinical relevance of the results"], "gold": []}, {"generated": ["clinical relevance"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["500\u2009mg valerian extract"], "gold": []}, {"generated": ["CYP 2E1", "CYP 1A2", "CYP 3A4/5", "CYP 2D6"], "gold": []}, {"generated": ["12 weeks", "15 days", "Haloperidol"], "gold": []}, {"generated": ["two drugs"], "gold": []}, {"generated": ["pharmacodynamic interaction"], "gold": []}, {"generated": ["delirium", "opioids", "MAO-inhibitory properties"], "gold": []}, {"generated": ["drug-drug interactions"], "gold": []}, {"generated": ["metabolism of extract components", "in vivo bioavailability"], "gold": ["bioavailability"]}, {"generated": ["pharmacodynamic interactions"], "gold": []}, {"generated": ["interactions", "therapeutic safety"], "gold": []}, {"generated": ["P-gp", "CYP-isoenzymes", "UGT"], "gold": []}, {"generated": ["warnings regarding a specific risk of interactions"], "gold": []}, {"generated": ["conflict of interests"], "gold": []}, {"generated": ["CYP3A inhibition", "CYP3A induction"], "gold": []}, {"generated": ["serotonin-norepinephrine reuptake inhibitor"], "gold": []}, {"generated": ["radiological abnormalities", "LVEF"], "gold": ["LVEF"]}, {"generated": ["drug-induced cardiopulmonary toxicity"], "gold": []}, {"generated": ["DIP", "reversibility"], "gold": []}, {"generated": ["cardiopulmonary toxicity"], "gold": []}, {"generated": ["cardiac catheterization", "myocardial biopsy", "detection of autoimmune diseases", "studies of imaging", "LBA"], "gold": []}, {"generated": ["inhibidores da isoenzima CYP2D6", "fen\u00f3tipo de metaboliza\u00e7\u00e3o lenta de CYP2D6"], "gold": []}, {"generated": ["prote\u00ednas do complemento", "renais", "sedimento urin\u00e1rio", "hep\u00e1ticos"], "gold": []}, {"generated": ["medicamentos card\u00edacos"], "gold": []}, {"generated": ["paciente", "h\u00edgida", "35 anos de idade"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["menopausal symptoms", "safety", "red ginseng", "herb extract complex (RHC)"], "gold": []}, {"generated": ["creatinine levels", "alanine aminotransferase (ALT)", "aspartate aminotransferase (AST)", "mammographies", "Pap smears"], "gold": ["fasting blood sugar", "triglyceride", "cholesterol", "alanine aminotransferase (ALT)", "aspartate aminotransferase (AST)", "creatinine"]}, {"generated": ["treatment of adverse reactions", "date of disappearance", "causal relationship with the test substance", "date of onset", "degree and result of the adverse reaction", "name of the drug other than the test substance"], "gold": []}, {"generated": ["characteristics", "demographic information"], "gold": []}, {"generated": ["p-value"], "gold": []}, {"generated": ["pruritus", "hot flash", "headache"], "gold": []}, {"generated": ["severe adverse reactions"], "gold": []}, {"generated": ["safety of RHC intake"], "gold": []}, {"generated": ["UGT2B7-catalyzed 4-MU glucuronidation", "UGT1A1-mediated 4-MU glucuronidation"], "gold": []}, {"generated": ["inhibition of compounds towards UGT isoforms"], "gold": []}, {"generated": ["competitive inhibition"], "gold": []}, {"generated": ["inhibition kinetic parameter (Ki)"], "gold": []}, {"generated": ["UGT1A6 expression", "serotonin glucuronidation"], "gold": []}, {"generated": ["valproic acid", "clofibric acid"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["4-MU glucuronidation", "UGT2B7"], "gold": []}, {"generated": ["anti-diabetic", "anti-oxidative", "anti-inflammatory"], "gold": []}, {"generated": ["probe substrates for five cytochrome P450 (CYP) enzymes", "CYP2C19", "CYP3A", "CYP2D6", "CYP1A2", "CYP2C9"], "gold": []}, {"generated": ["RGE", "Oatp", "ginsenosides", "OATP"], "gold": []}, {"generated": ["herb\u2013drug interactions involving valsartan"], "gold": []}, {"generated": ["unbound fraction of tri-glycosylated PPD-type ginsenosides", "plasma concentration"], "gold": []}, {"generated": ["ginsenosides", "plasma samples", "valsartan"], "gold": []}, {"generated": ["2", "0.33", "8", "0.67", "4", "48", "1.5", "24", "0.17"], "gold": []}, {"generated": ["Rd", "PPT", "Rc", "PPD", "Rb1", "Rb2"], "gold": []}, {"generated": ["rats", "plasma concentration-time curve", "pharmacokinetic parameters", "Rc", "valsartan", "dose", "intravenous injection", "AUC"], "gold": ["AUC: area under the plasma"]}, {"generated": ["efficacy", "potential for interactions with other drugs", "safety"], "gold": ["efficacy and safety"]}, {"generated": ["deviation of \u00b11 day"], "gold": []}, {"generated": ["study participants"], "gold": []}, {"generated": ["CAT", "SOD", "GPx", "MDA"], "gold": ["catalase (CAT)", "glutathione peroxidase (GPx)", "superoxide dismutase (SOD)", "malondialdehyde (MDA)"]}, {"generated": ["antioxidant and polyphenolic properties"], "gold": []}, {"generated": ["blood glucose", "insulin"], "gold": ["insulin", "blood glucose"]}, {"generated": ["hesperidin", "terpenoids (limonene and linalool)", "cytoprotective effects", "polymethoxylated flavonoids (PMF)"], "gold": []}, {"generated": ["antioxidants", "SOD", "CAT", "MDA"], "gold": ["SOD", "CAT", "MDA"]}, {"generated": ["Clevenger type apparatus", "Na Total flavonoids", "hydrodistillation", "Folin-Ciocalteau reagent"], "gold": []}, {"generated": ["reference value", "calibration curve", "standard"], "gold": []}, {"generated": ["standard deviation (SD)", "percentage", "measures of dispersion", "measures of central tendency", "frequency", "mean"], "gold": []}, {"generated": ["CC with herbal mixture", "herbal mixture", "CC"], "gold": []}, {"generated": ["FBS level", "HOMA-IR level", "insulin level"], "gold": ["FBS level", "insulin level", "HOMA-IR level"]}, {"generated": ["antioxidant activity"], "gold": []}, {"generated": ["CAT", "SOD", "GPx", "MDA"], "gold": ["SOD", "CAT", "GPx", "MDA"]}, {"generated": ["serotonin receptors", "FBS level", "pancreatic \u03b2 cells", "insulin"], "gold": ["FBS level"]}, {"generated": ["phenolic phytochemicals", "spearmint"], "gold": []}, {"generated": ["insulin tolerance", "glucose levels"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["lipid profile", "secretory phase", "sexual hormones", "proliferative phase"], "gold": []}, {"generated": ["Polycystic ovary syndrome (PCOS)"], "gold": []}, {"generated": ["volatile compounds"], "gold": []}, {"generated": ["darunavir concentrations"], "gold": []}, {"generated": ["Spain", "Madrid", "Arkopharma", "V05895B"], "gold": []}, {"generated": ["chemistry", "HIV-1 RNA load", "CD4+ T-cell count", "blood counts", "clinical interview", "physical examination"], "gold": ["blood counts", "CD4+ T-cell count"]}, {"generated": ["pharmacokinetic parameters", "analysis of variance model", "treatment as a fixed effect", "confidence intervals", "natural log transformed"], "gold": []}, {"generated": ["CD4+ T-cell count"], "gold": ["CD4+ T-cell count"]}, {"generated": ["HIV-1 RNA load"], "gold": ["HIV-1 RNA load"]}, {"generated": ["Darunavir pharmacokinetics"], "gold": []}, {"generated": ["darunavir pharmacokinetic parameters", "C\u03c4", "AUC\u03c4"], "gold": ["C\u03c4", "AUC\u03c4"]}, {"generated": ["pharmacokinetic parameters", "ritonavir concentration-versus-time profile"], "gold": []}, {"generated": ["clinical pharmacokinetic interactions"], "gold": []}, {"generated": ["darunavir pharmacokinetics", "CYP3A4 inductive/inhibitory potential"], "gold": []}, {"generated": ["E. purpurea"], "gold": []}, {"generated": ["metabolic drug\u2013drug interactions", "major CYP enzymes"], "gold": ["CYP enzymes"]}, {"generated": ["Ginkgo biloba extract"], "gold": []}, {"generated": ["EGb 761\u00ae 240 mg", "EGb 761\u00ae 120 mg"], "gold": []}, {"generated": ["5-OH-OME", "DEX", "DOR", "MID", "OME"], "gold": []}, {"generated": ["bioequivalence approach", "adjusted margins", "phenotyping metrics"], "gold": []}, {"generated": ["EGb 761"], "gold": []}, {"generated": ["steady state", "CYPs induction", "EGb 761\u00ae daily dose", "exposure duration"], "gold": []}, {"generated": ["CYP2C9", "CYP1A2"], "gold": ["CYP1A2", "CYP2C9"]}, {"generated": ["CYP2C19 activity"], "gold": ["CYP2C19 activity"]}, {"generated": ["pharmacodynamic (PD) parameters", "pharmacokinetic (PK) parameters"], "gold": ["pharmacokinetic (PK)-pharmacodynamic (PD) parameters"]}, {"generated": ["PK-PD parameters", "warfarin", "herbal medicines"], "gold": ["PK-PD parameters"]}, {"generated": [], "gold": []}, {"generated": ["participants"], "gold": []}, {"generated": ["herb"], "gold": []}, {"generated": ["study selection", "data extraction"], "gold": []}, {"generated": ["composition", "bioanalytical data", "extraction and formulation method"], "gold": []}, {"generated": ["attrition"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["reporting percentage"], "gold": []}, {"generated": ["PD interactions of warfarin with herbal medicines"], "gold": []}, {"generated": ["herb-warfarin interaction"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["metabolism of drugs metabolized by CYP2C9"], "gold": ["CYP2C9"]}, {"generated": ["CYP enzyme activity", "liver"], "gold": ["CYP enzyme activity"]}, {"generated": [""], "gold": []}, {"generated": [], "gold": []}, {"generated": ["warfarin"], "gold": []}, {"generated": ["prothrombin time", "activated partial thromboplastin time", "international normalized ratio"], "gold": ["prothrombin time (PT)", "activated partial thromboplastin time (aPTT)", "international normalized ratio (INR)"]}, {"generated": ["warfarin or super-warfarin exposure", "vitamin K malabsorption", "disseminated intravascular coagulation (DIC)", "pathologic inhibitors of coagulation"], "gold": []}, {"generated": ["WSU Institutional Review Board"], "gold": []}, {"generated": ["oxygen saturation", "blood pressure", "pulse"], "gold": ["Vital signs (blood pressure, pulse, oxygen saturation)"]}, {"generated": ["time of administration", "volume used to aid swallowing", "pill diary", "adverse events", "beverage", "Siliphos"], "gold": ["approximate volume used to aid swallowing"]}, {"generated": ["SAS Institute", "terminal elimination rate constant"], "gold": []}, {"generated": ["herb\u2013drug interactions", "ADME processes", "constituents"], "gold": ["ADME processes"]}, {"generated": ["silibinin", "silibinin\u2013raloxifene interaction", "glucuronidation"], "gold": ["intestinal glucuronidation"]}, {"generated": ["interaction potential"], "gold": []}, {"generated": ["conjugative metabolism"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["pure powder capsule", "Curcumin", "95%"], "gold": []}, {"generated": ["percent blood glucose reduction"], "gold": []}, {"generated": ["curcumin"], "gold": []}, {"generated": ["other herbs/botanicals", "food", "dietary supplements", "Traditional Chinese medicine"], "gold": []}, {"generated": ["pharmacokinetic properties", "herbal products", "drugs", "coadministered substances", "food"], "gold": []}, {"generated": ["CBZ"], "gold": []}, {"generated": ["Cochrane Database of Systematic Reviews"], "gold": []}, {"generated": ["traditional hypoglycemic herbs"], "gold": []}, {"generated": ["pharmacokinetic parameters", "oral bioavailability"], "gold": ["oral bioavailability"]}, {"generated": ["nicotinamide", "CBZ plasma level"], "gold": ["clearance"]}, {"generated": ["antiepileptic therapy"], "gold": []}, {"generated": [""], "gold": []}, {"generated": [], "gold": []}, {"generated": ["plasma level of CBZ", "gastric absorption"], "gold": []}, {"generated": ["beverage containing alcohol"], "gold": []}, {"generated": ["CBZ-related side effects", "nausea", "blurred vision", "dizziness", "skin rash"], "gold": []}, {"generated": ["individual herbs"], "gold": []}, {"generated": ["herbal medicines"], "gold": []}, {"generated": ["use of herbal medicines"], "gold": []}, {"generated": ["significant relationship"], "gold": []}, {"generated": ["Table 1"], "gold": []}, {"generated": ["age group"], "gold": []}, {"generated": ["hypoglycaemic agents", "pharmacological agents", "pharmacological management"], "gold": []}, {"generated": ["pharmacological evidence", "traditional use in diabetes management"], "gold": []}, {"generated": ["pharmacokinetic parameters", "modulators", "substrates", "drug interactions"], "gold": []}, {"generated": ["herbal medicines"], "gold": []}, {"generated": ["herb\u2013drug interactions"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["liver-specific enzymes"], "gold": ["liver-specific enzymes"]}, {"generated": ["elimination half-life"], "gold": ["an elimination half-life"]}, {"generated": ["22 compounds"], "gold": []}, {"generated": ["PNS", "BNPP"], "gold": ["BNPP"]}, {"generated": ["liver drug enzymes"], "gold": ["Liver drug enzymes"]}, {"generated": [], "gold": []}, {"generated": ["PON influence test"], "gold": ["PON"]}, {"generated": ["Total RNA"], "gold": ["Total RNA"]}, {"generated": ["HDI"], "gold": []}, {"generated": ["conceived and designed the whole experiments"], "gold": []}, {"generated": ["p-values"], "gold": []}, {"generated": ["pharmacological safety"], "gold": []}, {"generated": ["drug transporters", "cytochrome P450 enzymes"], "gold": []}, {"generated": ["intracellular calcein fluorescence", "P-glycoprotein"], "gold": []}, {"generated": ["CYP3A4 inhibition", "CYP2C19 inhibition"], "gold": []}, {"generated": ["aryl hydrocarbon receptor (AhR)", "Samento", "omeprazole"], "gold": []}, {"generated": ["drug metabolizing enzymes", "drug transporters"], "gold": []}, {"generated": ["drug metabolizing enzymes", "drug transporters"], "gold": ["bioavailability"]}, {"generated": ["BCRP", "pheophorbide A"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Banderol", "Samento"], "gold": []}, {"generated": ["RNA", "cDNA"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Banderol", "Samento"], "gold": []}, {"generated": ["HEK-OATP1B1 and HEK-OATP1B3 cell lines", "AZ-AhR cells", "MDCKII-BCRP cells", "P388 and P388/dx cells"], "gold": []}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["pregnane x receptor (PXR) activity"], "gold": []}, {"generated": ["protein expression of P-glycoprotein (P-gp)"], "gold": []}, {"generated": ["CYP2J2 mRNA decay"], "gold": []}, {"generated": ["CYP2J2 mRNA", "\u03b22mg", "t = 0", "RT-PCR"], "gold": []}, {"generated": ["drug interactions"], "gold": []}, {"generated": ["tablet form"], "gold": []}, {"generated": ["Korean Pharmaceutical Codex", "aqueous suspension"], "gold": []}, {"generated": ["Bovis Calculus", "Antelopis Cornu", "Scutellariae Radix", "Glycyrrhizae Radix et Rhizoma", "Massa Medicata Fermentata", "Cnidii Rhizoma", "Cinnamomi cortex", "Ginseng Radix", "Saposhnikoviae Radix", "Atractylodis Rhizoma Alba", "Armeniacae Semen", "Bupleuri Radix", "Paeoniae Radix", "Borneolum", "Glycine Semen Germinatum", "Liriopis Tuber", "Poria Sclerotium", "Angelicae Gigantis Radix", "Dioscoreae Rhizoma", "Platycodonis Radix"], "gold": []}, {"generated": ["over the counter medications", "prescription medications"], "gold": []}, {"generated": ["CYP2B6 genotyping"], "gold": []}, {"generated": ["safety monitoring"], "gold": []}, {"generated": ["5500 V", "500\u00b0C", "positive ion mode"], "gold": []}, {"generated": ["Foster City, CA", "Analyst software", "version 1.4", "Applied Biosystems"], "gold": []}, {"generated": ["Cmax", "AUC(0,\u221e)"], "gold": ["AUC(0,\u221e)", "Cmax"]}, {"generated": ["90% confidence intervals", "geometric mean ratios"], "gold": []}, {"generated": ["blood pressure", "body temperature", "heart rate"], "gold": ["blood pressure", "heart rate", "body temperature"]}, {"generated": ["bupropion", "CYP2B6 inhibitory effects", "pharmacokinetics"], "gold": []}, {"generated": ["pomegranate", "grapefruit", "statins"], "gold": []}, {"generated": ["tyrosine kinases"], "gold": []}, {"generated": ["Pgp/MDR1 protein"], "gold": []}, {"generated": ["BCRP/ABCG2 protein expression"], "gold": []}, {"generated": ["DAS", "inhibition", "BCPR/ABCG2 protein"], "gold": []}, {"generated": ["drug transporters", "drug-metabolizing enzymes (DME)"], "gold": []}, {"generated": ["APG", "DAS"], "gold": []}, {"generated": ["pharmacokinetic parameters"], "gold": []}, {"generated": ["12 h fasting", "25 \u00b0C", "12-h light/dark cycle"], "gold": []}, {"generated": ["DAS (25 mg/kg)", "Group I", "Group II"], "gold": []}, {"generated": ["Group IV", "2 h after", "APG 40 mg/kg administration", "7th day"], "gold": []}, {"generated": ["electrospray ionization"], "gold": []}, {"generated": ["APG\u2013DAS interaction"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["supervision"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Research Ethics Committee of King Saud University College of Pharmacy Riyadh", "KSU-SE-21-58"], "gold": []}, {"generated": ["SD", "average"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["cytochrome P-450 activity"], "gold": []}, {"generated": ["CYP activity"], "gold": []}, {"generated": ["botanical supplements"], "gold": []}, {"generated": ["lactate at rest", "quadriceps muscle strength (QMS)"], "gold": ["quadriceps muscle strength (QMS)", "lactate"]}, {"generated": ["lactate level", "QMS"], "gold": ["lactate level"]}, {"generated": ["muscle strength"], "gold": ["muscle strength"]}, {"generated": ["angular velocity", "2 min", "isokinetic knee extensions"], "gold": []}, {"generated": ["isokinetic dynamometer", "femoral epicondyles", "knee joint center"], "gold": []}, {"generated": ["plasma samples"], "gold": []}, {"generated": ["placebo compliance", "SC extract supplementation"], "gold": []}, {"generated": ["height", "BMI", "weight"], "gold": ["BMI"]}, {"generated": ["resting lactate level"], "gold": ["lactate level"]}, {"generated": ["high lactate production", "reduced oxidative metabolism"], "gold": ["lactate"]}, {"generated": ["efficacy", "bioavailability"], "gold": ["bioavailability"]}, {"generated": ["pregnane\u2010X\u2010receptor (PXR) activation"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["flavonoids", "hypericin", "hyperforin"], "gold": []}, {"generated": ["time of immobility"], "gold": []}, {"generated": ["PXRRE", "xenobiotic receptor", "xenosensor", "PXR"], "gold": []}, {"generated": ["hyperforin", "OATP2B1"], "gold": []}, {"generated": ["clinically relevant interactions"], "gold": []}, {"generated": ["bioinformatics", "data mining", "pharmacoepidemiology methods"], "gold": []}, {"generated": ["clinical outcomes"], "gold": []}, {"generated": ["dosage differences"], "gold": []}, {"generated": ["literature selection", "database searching"], "gold": []}, {"generated": ["delayed hypersensitivity", "caspase 3 and 8 expression and activity", "survival time", "cytotoxicity", "phagocytic activity", "intestinal damage caused by 5-FU", "T cell apoptosis", "antibody production", "T cells count (CD4, CD4/CD8)", "caspase 3 activity", "symptomatic relief", "platelets", "cell cycle arrest", "metastasis", "tumor inhibition effect", "Bax expression", "appetite", "WBC (CD3+, CD4+ T cells, NK cells)"], "gold": ["T cell apoptosis", "caspase 3 activity", "Bax expression", "cells count", "CD4", "CD4", "CD8", "WBC", "CD3+", "CD4+ T cells", "NK cells", "platelets", "WBC", "platelets", "bone marrow cells", "phagocytic activity", "antibody production", "caspase 3"]}, {"generated": ["metastasis", "tumor recurrence"], "gold": []}, {"generated": ["reactive oxygen species production", "tumor cell angiogenesis"], "gold": []}, {"generated": ["Warburg-related proteins", "gut dysbiosis"], "gold": []}, {"generated": ["cytotoxic and tumor-infiltrating lymphocytes", "lipid peroxide levels", "superoxide dismutase (SOD)", "suppressor T cells"], "gold": ["suppressor T cells", "superoxide dismutase (SOD)", "lipid peroxide levels"]}, {"generated": ["traditional hypoglycemic herbs"], "gold": []}, {"generated": ["PD-1", "T-bet", "caspase 3", "GATA-3", "Foxp3", "Bax"], "gold": []}, {"generated": ["medicinal mushrooms"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["accuracy", "accountability", "work", "integrity"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["complementary and alternative (CAM) treatment options"], "gold": []}, {"generated": ["estrogen receptor (ER) positive"], "gold": []}, {"generated": ["breast cancer patients", "other types of cancer", "Viscum album extracts"], "gold": []}, {"generated": ["total mistletoe lectin concentration"], "gold": []}, {"generated": ["dextrorphan-d", "\u03b2-estradiol", "HLMs"], "gold": []}, {"generated": ["proliferation"], "gold": []}, {"generated": ["intermediate", "ultra-rapid metabolizers", "extensive", "poor"], "gold": []}, {"generated": ["CYP2D6 metabolic activity", "long-term outcomes in breast cancer"], "gold": []}, {"generated": ["genetic polymorphisms", "CYP2D6 activity"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["quinidine", "CYP2D6"], "gold": []}, {"generated": ["institutional affiliations", "jurisdictional claims"], "gold": []}, {"generated": ["pharmacokinetic interactions"], "gold": []}, {"generated": ["plasma captopril", "ammonia solution", "2-4-dibromoacetophenone"], "gold": []}, {"generated": ["p.o.", "captopril dose"], "gold": []}, {"generated": ["anaesthetized"], "gold": []}, {"generated": ["body fluid"], "gold": []}, {"generated": ["within-run accuracy", "precision"], "gold": []}, {"generated": ["rats plasma"], "gold": []}, {"generated": ["sulfhydryl group", "2-4-dibromoacetophenone"], "gold": []}, {"generated": ["Ammonia"], "gold": []}, {"generated": ["formic acid"], "gold": []}, {"generated": ["expression of the PEPT1 transporter", "GSH level"], "gold": []}, {"generated": ["Eng et al."], "gold": []}, {"generated": ["traditional hypoglycemic herbs"], "gold": []}, {"generated": ["laboratory rodent chow"], "gold": []}, {"generated": ["Agilent 1290 series liquid chromatography system"], "gold": []}, {"generated": ["Student\u2019s paired t-test"], "gold": []}, {"generated": ["herb-drug interaction"], "gold": []}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": [""], "gold": []}, {"generated": [""], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Eugenia jambolana"], "gold": []}, {"generated": ["blood glucose level"], "gold": ["blood glucose level"]}, {"generated": ["bioactive constituents", "dipeptidyl peptidase-4 (DDP-4)"], "gold": []}, {"generated": ["efficacy", "safety"], "gold": []}, {"generated": ["double maceration technique", "Eugenia jambolana", "dried seed", "aqueous extract"], "gold": []}, {"generated": ["filtrate"], "gold": []}, {"generated": ["filtrate"], "gold": []}, {"generated": ["glucose level"], "gold": ["Glucose level"]}, {"generated": ["3a", "3b"], "gold": []}, {"generated": ["PRM", "SITA"], "gold": []}, {"generated": ["inflammatory response", "oxidative stress"], "gold": []}, {"generated": ["SEM", "mean"], "gold": []}, {"generated": ["diabetic control group", "normal group"], "gold": []}, {"generated": ["BUN levels"], "gold": ["BUN"]}, {"generated": ["Table 2"], "gold": []}, {"generated": ["diabetic control group", "normal group"], "gold": []}, {"generated": ["pharmacokinetic parameters"], "gold": []}, {"generated": ["indomethacin", "metabolites", "bile", "feces"], "gold": []}, {"generated": ["plasma sample preparation", "tissue homogenates"], "gold": []}, {"generated": ["M-AOE group", "model group"], "gold": []}, {"generated": ["4\u20135 h", "1\u20132 h", "5\u20136 h", "2\u20133 h", "3\u20134 h", "0\u20131 h", "6\u20137 h"], "gold": []}, {"generated": ["18\u201328 h", "6\u201318 h", "0\u20136 h"], "gold": []}, {"generated": ["selectivity", "recovery", "linearity", "accuracy", "stability", "matrix effect", "precision", "dilution integrity"], "gold": []}, {"generated": ["pharmacokinetics"], "gold": []}, {"generated": ["plasma concentration-time curves"], "gold": []}, {"generated": ["traditional hypoglycemic herbs"], "gold": []}, {"generated": ["1.875 mg", "1.7\u20132.5", "INR", "warfarin"], "gold": ["INR", "monitoring"]}, {"generated": ["moderate intake of alcohol", "anticoagulant therapy", "thrombin times (TTs)"], "gold": ["thrombin times (TTs)"]}, {"generated": ["Dong quai", "Danshen", "Ginkgo biloba"], "gold": []}, {"generated": ["Gouqizi"], "gold": []}, {"generated": ["China", "atrial fibrillation", "bleeding", "warfarin"], "gold": []}, {"generated": ["daily Gouqizi dose", "concomitantly taking warfarin", "prosthetic heart values"], "gold": []}, {"generated": ["conflict of interests"], "gold": []}, {"generated": ["Lycium barbarum L.", "warfarin"], "gold": []}, {"generated": ["blood pressure"], "gold": ["blood pressure"]}, {"generated": ["anthocyanins", "cyanidin-3-sambubioside", "delphinidin-3-sambubioside"], "gold": []}, {"generated": ["antioxidant activity"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["total cholesterol", "HDL-C", "LDL-C", "triglycerides"], "gold": ["Cholesterol", "cholesterol", "total cholesterol", "HDL-C", "LDL-C", "triglycerides"]}, {"generated": ["total cholesterol"], "gold": ["total cholesterol"]}, {"generated": ["RCT", "study design"], "gold": []}, {"generated": [], "gold": ["calcium influx", "myocardial mass", "blood viscosity", "cyclooxygenase inhibitory activity", "adipocyte differentiation", "PI3-K/Akt", "ERK"]}, {"generated": ["liver function", "kidney function", "hepatotoxicity"], "gold": []}, {"generated": ["electrolyte levels"], "gold": ["electrolyte levels"]}, {"generated": [""], "gold": []}, {"generated": ["interaction"], "gold": []}, {"generated": ["bosutinib systemic exposure"], "gold": []}, {"generated": ["modelling and simulation", "herb\u2013drug interactions", "drug metabolism", "physiologically\u2010based pharmacokinetic (PBPK)"], "gold": []}, {"generated": ["herb\u2013drug interactions"], "gold": []}, {"generated": ["traditional hypoglycemic herbs"], "gold": []}, {"generated": [""], "gold": []}, {"generated": [], "gold": ["recombinant CYP2C8 enzyme (supersomes)", "human liver microsomes (HLM)"]}, {"generated": ["cooling block", "NADPH"], "gold": ["NADPH"]}, {"generated": ["competitive", "noncompetitive", "mixed-inhibition"], "gold": []}, {"generated": ["competitive inhibition", "K m values", "noncompetitive inhibition"], "gold": ["concentrations of substrates", "K m values"]}, {"generated": ["Partition coefficients (log P)"], "gold": ["Partition coefficients (log P)"]}, {"generated": ["K p (tissue\u2010to\u2010plasma partition coefficients)", "tissue composition", "log P"], "gold": ["log P", "K p (tissue\u2010to\u2010plasma partition coefficients)"]}, {"generated": ["pharmacokinetic parameters", "PBPK model prediction", "clinically-reported parameter values"], "gold": []}, {"generated": ["Schisandra lignans", "PBPK models", "midazolam", "tacrolimus"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["MBI"], "gold": []}, {"generated": ["CYP3A inhibition"], "gold": []}, {"generated": ["Schisandra lignans"], "gold": ["CYP"]}, {"generated": ["anti\u2010cancer activity"], "gold": []}, {"generated": ["haemorrhage"], "gold": []}, {"generated": ["Gegen", "Danshen", "warfarin"], "gold": []}, {"generated": ["mRNA expression", "protein expression"], "gold": []}, {"generated": ["TM", "VKOR"], "gold": []}, {"generated": ["morphological authentication", "thin layer chromatography", "Chinese Pharmacopoeia 2005"], "gold": []}, {"generated": ["naringin", "diclofenac sodium"], "gold": []}, {"generated": ["13 min", "10 min", "30 min", "17%", "10%", "5 min", "solvent A", "15 min", "90%", "35%", "5%", "12 min"], "gold": []}, {"generated": ["mRNA expression ratio of CYP2C6"], "gold": []}, {"generated": ["mRNA expression level of CYP2C6"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["TM", "microcirculation", "VKOR", "platelet aggregation"], "gold": []}, {"generated": ["PT time", "warfarin plasma concentration"], "gold": ["PT time"]}, {"generated": ["Gegen"], "gold": []}, {"generated": ["Danshen"], "gold": []}, {"generated": ["CYP enzymes"], "gold": []}, {"generated": ["catalytic activity", "catalytic specificity"], "gold": []}, {"generated": ["predictive models", "warfarin dose", "physical factors", "genetic factors"], "gold": []}, {"generated": ["CYP1A-", "CYP2C-", "CYP3A-inducing agents"], "gold": []}, {"generated": ["warfarin hydroxylation"], "gold": []}, {"generated": ["SAB", "bioavailability"], "gold": ["bioavailability"]}, {"generated": ["discrepancies observed between the in vitro and in vivo results"], "gold": []}, {"generated": ["beta-naphthoflavone", "liver cytochrome P450", "vitamin K epoxide reductase", "thrombomodulin", "salvianolic acid B", "Danshen\u2013Gegen Formula", "phenobarbital", "enzyme-linked immunosorbent assay", "cyclosporine", "vitamin K"], "gold": []}, {"generated": ["toxicity profile"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["analyte"], "gold": []}, {"generated": ["endogenous peaks"], "gold": []}, {"generated": ["range 4\u2013113 months", "mean of 37 months"], "gold": []}, {"generated": ["conflicts of interests"], "gold": []}, {"generated": ["dietary supplements", "herbal medicines"], "gold": []}, {"generated": ["antimicrobials", "asthma", "cancer", "hypertension", "peptic ulcer", "minor ailments", "antimalarials", "diabetes"], "gold": []}, {"generated": ["isoenzymes"], "gold": []}, {"generated": ["metabolic capacity of CYP isoenzymes"], "gold": []}, {"generated": ["freeze\u2010dried"], "gold": []}, {"generated": ["HPLC\u2010grade acetonitrile", "Acetic acid"], "gold": []}, {"generated": ["CYP isoenzymes", "concentration used in the N\u2010in\u2010one assay"], "gold": []}, {"generated": ["positive ion mode", "MRM mode"], "gold": []}, {"generated": ["50% inhibitory concentration", "concentration of aqueous extract of herb"], "gold": ["Fifty percent inhibitory concentration"]}, {"generated": [], "gold": []}, {"generated": ["major human CYP isoenzymes"], "gold": []}, {"generated": ["assay method", "enzyme sources", "concentration", "extraction procedure", "type of the extract", "CYP isoenzymes"], "gold": []}, {"generated": ["Allium sativum bulbs", "aqueous extract"], "gold": []}, {"generated": ["CYP2C9", "CYP1A2"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["(2000)"], "gold": []}, {"generated": ["CYP2C19", "CYP3A4", "CYP1A2"], "gold": ["IC"]}, {"generated": ["polyherbal formulation", "menopause symptoms"], "gold": []}, {"generated": ["cognitive declines", "sexual dysfunction", "hot flashes", "night sweats", "sleep disturbances", "mood disorders", "weight gain"], "gold": []}, {"generated": ["ammonium acetate"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["gastrointestinal disease", "endocrine disease", "cardiovascular disease", "dermatologic disease", "neurologic disease/disorder", "hematologic disease", "renal disease", "pulmonary disease", "hepatic disease", "immunologic disease"], "gold": []}, {"generated": ["planning to conceive within 30 days of treatment cessation", "breastfeeding", "pregnant"], "gold": ["serum human chorionic gonadotropin"]}, {"generated": ["MenoAct851 formulation", "placebo", "double-blind"], "gold": []}, {"generated": ["sequentially numbered drug containers"], "gold": []}, {"generated": ["plasma concentrations", "simvastatin hydroxy acid", "internal standard", "simvastatin", "lovastatin"], "gold": []}, {"generated": ["SD", "mean"], "gold": []}, {"generated": ["P < 0.05"], "gold": []}, {"generated": ["40 mg simvastatin"], "gold": []}, {"generated": ["herbal formulations", "bioavailability", "herbal medicines"], "gold": ["bioavailability"]}, {"generated": ["stent", "fatigue", "hypertension", "bleeding", "diabetes"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["interactions between medication and lifestyle"], "gold": []}, {"generated": ["drug \u2013 lifestyle", "drug interactions"], "gold": []}, {"generated": ["echinacea", "policosanol"], "gold": []}, {"generated": ["CYP2C9*2", "CYP2C9*3", "CYP2C9*1"], "gold": []}, {"generated": ["adverse events"], "gold": []}, {"generated": ["Adenosine diphosphate", "Mean (95% CI)", "Arachidonic acid", "Platelet aggregation (Ohms)", "Collagen", "Open in a separate window", "Geometric mean ratio to control (90% CI)"], "gold": ["Platelet aggregation"]}, {"generated": ["Cmax", "trough plasma concentrations"], "gold": ["Cmax"]}, {"generated": ["warfarin pharmacodynamics", "pharmacokinetics"], "gold": []}, {"generated": [""], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["awareness of herb-drug use", "herb-drug use"], "gold": []}, {"generated": ["Hypericum perforatum", "Allium sativum", "Panax ginseng", "Ginkgo biloba"], "gold": []}, {"generated": ["CYP1A2 activity"], "gold": []}, {"generated": ["CYP assays"], "gold": []}, {"generated": ["deoxydehydropodophyllotoxin", "\u03b2-Sitosterol", "dehydro-b-peltatin methyl ether", "cadina-4,10(15)-dien-3-one", "4\u2032-demethyldesoxypodophyllotoxin", "5\u2032-methoxydehydropodophyllotoxin", "dehydropodophyllotoxin"], "gold": []}, {"generated": ["suction-filtered", "type 1 Whatman filter paper"], "gold": []}, {"generated": ["chromatographic methods"], "gold": []}, {"generated": ["Waters Alliance 2690 HPLC", "Waters LCT Time of Flight Mass Spectrometer", "High resolution LC-MS"], "gold": []}, {"generated": ["CYPs 1A1, 1A2, 1B1, 3A4, 2D6", "cytochrome P450 enzymes"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["concentrations of the extracts", "2,2-diphenyl-1-picrylhydrazyl (DPPH)"], "gold": []}, {"generated": ["dried", "aqueous extract", "H. verticillata", "aerial", "phytochemicals"], "gold": []}, {"generated": ["area under the plasma concentration-time curve", "area under the first moment of plasma drug concentration-time curve"], "gold": ["area under the plasma concentration-time curve", "area under the first moment of plasma drug concentration-time curve"]}, {"generated": [], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["symptoms"], "gold": []}, {"generated": ["rashes caused by Lomatium", "treatment"], "gold": []}, {"generated": ["rash", "antihistamines"], "gold": []}, {"generated": ["selected single herbs", "OS", "Wen Bing formulas"], "gold": []}, {"generated": ["quality of control standard number", "Radix Scutellariae extract", "batch number"], "gold": []}, {"generated": ["Albuterol"], "gold": []}, {"generated": ["thiazolyl blue tetrazolium bromide (MTT)", "Hygromycin B", "glycyl-sarcosine (Gly-Sar)"], "gold": []}, {"generated": ["dichlorvos", "PBS"], "gold": []}, {"generated": ["antiviral activity"], "gold": []}, {"generated": ["OS", "rat plasma"], "gold": []}, {"generated": ["OSA"], "gold": []}, {"generated": ["ten marker components"], "gold": []}, {"generated": ["absorption", "metabolism", "HDI"], "gold": []}, {"generated": ["OSA", "systemic exposure of OS"], "gold": []}, {"generated": ["OSA/OS ratio"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["cells", "enzymes", "microsomes", "influenza viruses"], "gold": []}, {"generated": ["herbal extracts", "hydrolysis of OS", "herbal components"], "gold": []}, {"generated": ["hydrolase activities", "hydrolysis enzymes"], "gold": []}, {"generated": ["absolute z-score", "HDI relevancy with OS"], "gold": []}, {"generated": [], "gold": ["BIO", "AUC"]}, {"generated": ["Radix Isatidis"], "gold": []}, {"generated": ["Fructus Arctii"], "gold": []}, {"generated": ["drug interactions"], "gold": []}, {"generated": ["clinical evidence", "TAM", "natural products"], "gold": []}, {"generated": ["complementary and alternative medicine (CAM) treatment"], "gold": []}, {"generated": ["Anemarrhena", "Phellodendron bark"], "gold": []}, {"generated": ["Licorice", "Lilyturf", "Ginger"], "gold": []}, {"generated": ["cell cycle arrest", "autophagy", "apoptosis"], "gold": []}, {"generated": ["cell apoptosis", "anti-proliferative effect"], "gold": []}, {"generated": ["synergistic inhibitory effect"], "gold": ["MCF-7 and T-47D cell growth"]}, {"generated": ["Mistletoe (Viscum album L.) derived medicinal preparations"], "gold": []}, {"generated": ["cell growth", "cell viability", "apoptosis", "TAM resistance"], "gold": ["cell viability", "cell growth"]}, {"generated": ["12 traditional herbs", "Jaeumkanghwa soup"], "gold": []}, {"generated": ["Jiawei Xiaoyao San"], "gold": []}, {"generated": ["protective effect"], "gold": []}, {"generated": ["glutathione", "sGOT", "liver transaminases", "sGPT", "antioxidant enzymes", "TBARS"], "gold": ["antioxidant enzymes", "the activity of sGPT and sGOT", "glutathione concomitant", "TBARS", "liver transaminases"]}, {"generated": ["transcription activity", "protein expression levels"], "gold": ["protein expression levels"]}, {"generated": ["BCRP", "OAT1/3", "MDR1"], "gold": []}, {"generated": ["Communicable diseases", "GBD Diseases and Injuries, 2020", "WHO\u2019s Global Health Estimates 2000\u20132019", "lead causes of death and disability"], "gold": []}, {"generated": ["urinary tract infections", "prostatitis", "pyelonephritis"], "gold": []}, {"generated": ["PCE tracer components"], "gold": []}, {"generated": ["CIP", "urine"], "gold": []}, {"generated": ["ATP-binding cassette transporters"], "gold": []}, {"generated": ["gradient elution program"], "gold": []}, {"generated": ["CIP", "GA", "PCA"], "gold": []}, {"generated": ["precursor-product ion transitions"], "gold": []}, {"generated": ["PCA", "GA", "PK changes"], "gold": []}, {"generated": ["tissue to plasma distribution coefficients", "K tissue distribution coefficients", "tissue distribution profiles", "tissue distribution curves"], "gold": []}, {"generated": ["tissue to plasma distribution coefficients", "tissue distribution profiles"], "gold": []}, {"generated": ["intestinal epithelia", "renal epithelia"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["potential conflict of interest"], "gold": []}, {"generated": [""], "gold": []}, {"generated": [], "gold": []}, {"generated": ["relative humidity", "air temperature", "barometric pressure"], "gold": []}, {"generated": ["extremely"], "gold": []}, {"generated": ["total AUC"], "gold": ["AUC", "CHO"]}, {"generated": ["treatment (YM vs. PLC)", "Total Energy Expenditure (TEE)", "exercise time"], "gold": ["Total Energy Expenditure (TEE)"]}, {"generated": ["24% increase"], "gold": []}, {"generated": ["blood lipid metabolites", "RER", "metabolic rate"], "gold": []}, {"generated": ["hypocholesterolemic properties", "vitamins", "caffeic acid", "anti-lipolytic", "di-caffeolquinic acids", "adrengenic effects", "quinic acid", "triterpenic saponins", "minerals", "mono-caffeolquinic acids"], "gold": []}, {"generated": ["bioavailability", "active ingredients"], "gold": ["bioavailability"]}, {"generated": ["mood state", "satiety", "psychomotor effects"], "gold": []}, {"generated": ["BF%", "fat-loss outcomes", "YM", "physically active"], "gold": []}, {"generated": ["R.A."], "gold": []}, {"generated": ["Prof. Yeong Bae Seo"], "gold": []}, {"generated": ["OCT2", "OAT3", "OATP1B3", "OAT1", "OATP1B1", "OCT1"], "gold": ["OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters"]}, {"generated": ["food", "water"], "gold": []}, {"generated": ["polyethylene tubing", "jugular vein"], "gold": ["anesthesia"]}, {"generated": ["Mass Hunter software", "LC-MS/MS system control", "data processing"], "gold": []}, {"generated": ["concomitant herbal use"], "gold": []}, {"generated": ["felodipine", "cytochrome P450", "P-glycoprotein"], "gold": []}, {"generated": ["ginseng", "ginkgo", "kava", "kratom", "terminalia/commiphora ayurvedic mixture", "echinacea", "valerian", "hydroxycut", "St. John\u2019s wort", "rhodiola", "piperine", "celery", "moringa"], "gold": []}, {"generated": ["CYP450 family", "DMEs", "bioactive components"], "gold": []}, {"generated": ["Anecdotal evidence", "clinical decisions", "consequences of HDIs"], "gold": []}, {"generated": ["anxiety and mood disorders", "fatigue and general well-being", "cardiovascular disorders", "symptoms of cognition decline and memory loss"], "gold": []}, {"generated": ["subtherapeutic serum levels", "toxicological autopsy", "seizure"], "gold": []}, {"generated": ["CYP3A4", "pharmacokinetic parameters", "midazolam", "AUC"], "gold": ["AUC"]}, {"generated": ["manic psychosis"], "gold": []}, {"generated": ["kavalactones"], "gold": []}, {"generated": ["CNS benefits"], "gold": []}, {"generated": ["clinically relevant interaction"], "gold": []}, {"generated": ["concentration", "circulation", "alertness", "diarrhea", "libido", "diabetes"], "gold": []}, {"generated": ["serotonergic effects", "CYP/P-gp induction"], "gold": []}, {"generated": ["CYP3A4"], "gold": []}, {"generated": ["oral administration"], "gold": []}, {"generated": ["dietary supplements"], "gold": []}, {"generated": ["P-gp", "CYP3A4"], "gold": []}, {"generated": ["neuropsychiatric drugs"], "gold": []}, {"generated": ["bioactive compounds"], "gold": []}, {"generated": ["calcineurin inhibitors"], "gold": []}, {"generated": ["narrow therapeutic window"], "gold": []}, {"generated": ["sirolimus", "tacrolimus", "tremors"], "gold": []}, {"generated": ["serum creatinine level"], "gold": ["serum creatinine level"]}, {"generated": ["herb\u2013drug interactions"], "gold": []}, {"generated": ["author contributions"], "gold": []}, {"generated": ["immunosuppressive drug"], "gold": []}, {"generated": ["immunosuppressive drugs"], "gold": []}, {"generated": ["Parsley"], "gold": []}, {"generated": ["transporter proteins", "metabolizing enzymes"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["serum creatinine level"], "gold": ["serum creatinine level"]}, {"generated": ["level of sirolimus"], "gold": []}, {"generated": [], "gold": []}, {"generated": ["n", "mean", "S. D."], "gold": []}, {"generated": ["herb-drug interaction", "AUC data"], "gold": ["AUC"]}, {"generated": ["et Zucc."], "gold": []}, {"generated": ["pretreatment period"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["Maxim extract"], "gold": []}, {"generated": ["Bilia and C\u00e9u Costas review"], "gold": []}, {"generated": ["knowledge of risks", "knowledge of benefits"], "gold": []}, {"generated": ["analgetic drugs"], "gold": []}, {"generated": ["species"], "gold": []}, {"generated": ["prevalence"], "gold": []}, {"generated": ["species used", "geographical area of this review"], "gold": []}, {"generated": ["plants"], "gold": []}, {"generated": ["Aloe vera"], "gold": []}, {"generated": ["hepatotoxic herbs"], "gold": []}, {"generated": ["short-term use", "opioids", "pain relief", "surgical intervention"], "gold": []}, {"generated": ["liver injury"], "gold": []}, {"generated": ["product quality"], "gold": []}, {"generated": ["cannabis preparations"], "gold": []}, {"generated": ["possible beneficial effects"], "gold": []}, {"generated": ["pulverized dried bulbs", "Allium sativum", "0.45% allicin"], "gold": []}, {"generated": ["ginkgolic acid content"], "gold": []}, {"generated": ["platelet inhibiting co-medication", "anticoagulant", "bleeding risk"], "gold": []}, {"generated": ["thrombin inhibition"], "gold": []}, {"generated": [""], "gold": []}, {"generated": [], "gold": []}, {"generated": ["HILI", "tea consumption"], "gold": []}, {"generated": ["HILI"], "gold": []}, {"generated": ["water", "green tea"], "gold": []}, {"generated": ["CYP susceptibility"], "gold": ["CYP"]}, {"generated": ["CY3A4", "2C9"], "gold": []}, {"generated": ["platelet aggregation"], "gold": ["platelet aggregation"]}, {"generated": ["ASA", "inter-individual variability", "AUC +28%"], "gold": ["AUC"]}, {"generated": ["individual susceptibility"], "gold": ["individual susceptibility"]}, {"generated": ["adverse effects", "natural"], "gold": []}, {"generated": ["Garcia-Alvarez", "HMP", "Valerian"], "gold": []}, {"generated": ["translation errors", "mentions to the wrong species"], "gold": []}, {"generated": ["institutional affiliations", "jurisdictional claims"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["antagonistic interactions", "clinical efficacy", "additive/synergistic interactions", "clinical safety"], "gold": []}, {"generated": ["pharmacodynamic HDI"], "gold": []}, {"generated": ["allyl", "sulfur compounds", "allyl thiosulfinates"], "gold": []}, {"generated": ["diabetic treatment"], "gold": []}, {"generated": ["blood sugar levels"], "gold": ["blood sugar"]}, {"generated": ["Lycium", "antidiabetics"], "gold": []}, {"generated": ["Lycium", "conventional antidiabetics"], "gold": []}, {"generated": [""], "gold": []}, {"generated": ["pharmacological data", "system-to-system methodology"], "gold": []}, {"generated": ["synergism"], "gold": []}, {"generated": ["institutional affiliations", "jurisdictional claims"], "gold": []}, {"generated": ["bronchitis", "convulsions", "asthma", "cough", "hysteria", "flatulence"], "gold": []}, {"generated": ["DEX", "dextrorphan (DOR)"], "gold": []}, {"generated": ["DEX", "CYP3A", "CYP2D6"], "gold": ["CYP3A", "CYP2D6"]}, {"generated": ["USP reference standard"], "gold": []}, {"generated": ["HPLC grade solvents", "General-purpose reagents"], "gold": []}, {"generated": ["Zorbax SB-CN column"], "gold": []}, {"generated": ["Asafetida", "DEX metabolites", "one-way analysis of variance (ANOVA)", "Scheffe\u2019s multiple comparison test", "P value"], "gold": []}, {"generated": ["formation of DOR", "DEX"], "gold": []}, {"generated": ["25 \u03bcg/ml concentration"], "gold": []}, {"generated": ["healthy human volunteers"], "gold": []}, {"generated": ["clinical study"], "gold": []}, {"generated": ["Asafetida", "CYP3A4 metabolic activity"], "gold": []}, {"generated": ["abemaciclib-related diarrhea"], "gold": []}, {"generated": ["loose stools", "fatigue"], "gold": []}]}